Gilead Sciences Prices $3 Billion Notes at 4.25%-4.90% Across Four Maturities
GILD•Gilead priced $3 billion of senior unsecured notes across four tranches: $500 M 4.25% due 2028, $1 B 4.40% due 2029, $1 B 4.60% due 2031 and $500 M 4.90% due 2034. Offering closes May 20, 2026, with proceeds for corporate purposes, including acquisitions and investments.
1. Pricing of Senior Unsecured Notes
Gilead Sciences has priced $3 billion of senior unsecured notes in four tranches: $500 million of 4.25% notes due 2028, $1 billion of 4.40% notes due 2029, $1 billion of 4.60% notes due 2031 and $500 million of 4.90% notes due 2034.
2. Proceeds Allocation
Net proceeds from the offering will fund general corporate purposes, including potential acquisitions, strategic transactions, investments and other growth initiatives.
3. Offering Closing
The registered public offering is expected to close on May 20, 2026, subject to customary closing conditions under Gilead’s effective shelf registration.
